D

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017

Watchlist Manager
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Watchlist
Price: 58.2 SAR 1.93%
Market Cap: 13.5B SAR
Have any thoughts about
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC?
Write Note

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
D
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Cash from Operating Activities
ď·Ľ304.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dallah Healthcare Company SJSC
SAU:4004
Cash from Operating Activities
ď·Ľ779.5m
CAGR 3-Years
37%
CAGR 5-Years
22%
CAGR 10-Years
19%
National Medical Care Company JSC
SAU:4005
Cash from Operating Activities
-ď·Ľ72m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mouwasat Medical Services Company SJSC
SAU:4002
Cash from Operating Activities
ď·Ľ958m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
14%
A
Al Hammadi Holding Co
SAU:4007
Cash from Operating Activities
ď·Ľ333.4m
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
8%
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Cash from Operating Activities
ď·Ľ3.2B
CAGR 3-Years
13%
CAGR 5-Years
18%
CAGR 10-Years
N/A
No Stocks Found

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Glance View

Market Cap
13.5B SAR
Industry
Health Care

In the bustling hub of healthcare innovation within the Kingdom of Saudi Arabia, Dr. Soliman Abdel Kader Fakeeh Hospital Company SCJSC stands out as a beacon of medical excellence and pioneering spirit. Founded to address the rising demand for quality healthcare services in the region, the company has grown from a single hospital into a comprehensive network of medical facilities. The core of its operations revolves around providing a full spectrum of healthcare services ranging from basic outpatient treatments to intricate surgical procedures and specialty care. The company integrates advanced medical technologies with a patient-focused care approach, ensuring that the population it serves receives both cutting-edge and compassionate treatment. Within its walls, dedicated teams of healthcare professionals work tirelessly to uphold a legacy of trust and expertise, attracting both local and international patients seeking superior medical attention. Financially, Dr. Soliman Abdel Kader Fakeeh Hospital Company operates through a multifaceted model that revolves around patient services, strategic partnerships, and insurance collaborations. By catering to a diverse array of medical needs, the company secures a steady revenue stream from its inpatient and outpatient services. Moreover, it has established alliances with various insurance companies, streamlining the payment processes for insured patients and enhancing financial access to healthcare services. Strategic expansions and the introduction of specialized units also contribute significantly to its revenue, allowing it to capture more market share and cater to niche medical needs. The organization's business acumen is evident in its ability to balance quality care with economic sustainability, ensuring its growth while maintaining high standards of healthcare delivery across the kingdom.

Intrinsic Value
41.72 SAR
Overvaluation 28%
Intrinsic Value
Price
D

See Also

What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Cash from Operating Activities?
Cash from Operating Activities
304.3m SAR

Based on the financial report for Dec 31, 2023, Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Cash from Operating Activities amounts to 304.3m SAR.

What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
32%

Over the last year, the Cash from Operating Activities growth was 32%.

Back to Top